A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 12, 2009

Higher Viral Loads Associated With Metabolic Syndrome

People with higher HIV levels are more likely to have a cluster of symptoms—called metabolic syndrome—associated with cardiovascular disease than people with lower viral loads, according to a study published in the December issue of the Journal of Acquired Immune Deficiency Syndromes.

For the last decade, scientists have been working diligently to understand why certain people with HIV appear to be at higher risk for developing cardiovascular disease. Though some have traditional risk factors, such as smoking or diabetes, many do not. In the earlier part of the last decade, researchers suspected that protease inhibitors (PIs) might be the primary reason for the increased cardiovascular disease risk.

Though PIs and other antiretrovirals (ARVs) appear to be associated with increases in blood lipids—cholesterol and triglycerides—which can contribute to an increased risk of cardiovascular disease, newer research suggests that HIV itself is also a factor. A leading theory is that chronic HIV infection leads to inflammation, ultimately causing abnormalities that strain the heart and its circulatory system. The greater the level of ongoing viral replications, some experts suggest, the greater the risk of cardiovascular disease.  

Nicola Squillace, MD, from the University of Modena and Reggio Emilia, in Modena, Italy, and her colleagues set out to determine whether higher viral loads would increase the likelihood that a person would develop metabolic syndrome—a cluster of symptoms that includes unhealthy changes in the levels of cholesterol, triglycerides and blood sugar, weight-gain in the gut area, and high blood pressure. People with metabolic syndrome, whether they are HIV positive or not, have a profoundly increased risk of heart attacks, strokes and other cardiovascular problems.

Squillace and her colleagues examined the medical records of all HIV-positive patients seen at the metabolic clinic at the University of Modena and Reggio Emilia between January 2006 and January 2008. Their analysis included more than 1,300 people; 63 percent were men; and the average age was about 45.

Metabolic syndrome was present in 23 percent of those with viral loads below 400 copies, compared with 32 percent in people with viral loads over 400. In particular, three specific symptoms of metabolic syndrome were far more common among people with higher viral loads: high blood pressure, high triglycerides and low levels of the “good” cholesterol, HDL.

PI use, even in the past, was also associated with metabolic syndrome. The degree of association between metabolic syndrome and PI use was not nearly as high, however, as the association between the syndrome and higher viral loads.

The authors conclude that an effective ARV regimen is “mandatory for both control of HIV disease progression and for prevention of [metabolic syndrome]-related disorders.” 

Search: Metabolic syndrome, blood sugar, cholesterol, triglycerides, HDL, hypertension, high blood pressure, cardiovascular disease, heart attack, stroke


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    CTMascMan
    New Haven
    Connecticut


    Shua84
    Seattle
    Washington


    astoria85
    nyc
    New York


    jonhart48
    Stamford
    Connecticut
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.